Patent 7560444 was granted and assigned to Momenta Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.
Formulation for pulmonary delivery of a therapeutic, prophylactic, or diagnostic agent including a low molecular weight heparin and a therapeutic, prophylactic, or diagnostic agent.